Sarepta Therapeutics (SRPT) Insider Trading & Ownership $110.86 +4.24 (+3.98%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sarepta Therapeutics (NASDAQ:SRPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$4.96 MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$11.65 M Get SRPT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SRPT Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Sarepta Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/30/2024Ian Michael EstepanCFOSell5,985$137.36$822,099.60 8/16/2024Michael Andrew ChambersDirectorBuy37,038$133.80$4,955,684.40 6/25/2024Ryan Edward BrownEVPSell38,957$161.61$6,295,840.77 6/24/2024Bilal ArifInsiderSell7,859$163.08$1,281,645.72 5/2/2024Dallan MurrayInsiderSell3,635$140.00$508,900.00 3/11/2024Kathryn Jean BoorDirectorSell761$122.93$93,549.73 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/8/2024Hans Lennart Rudolf WigzellDirectorSell15,000$123.25$1,848,750.00 3/5/2024Stephen MayoDirectorSell3,135$122.96$385,479.60 3/1/2024Bilal ArifInsiderSell2,000$128.84$257,680.00 3/1/2024Ian Michael EstepanCFOSell1,200$128.30$153,960.00 (Data available from 1/1/2013 forward) SRPT Insider Trading Activity - Frequently Asked Questions Who is on Sarepta Therapeutics's Insider Roster? The list of insiders at Sarepta Therapeutics includes Bilal Arif, Dallan Murray, Douglas S Ingram, Hans Lennart Rudolf Wigzell, Ian Michael Estepan, Kathryn Jean Boor, Louise Rodino-Klapac, Michael Andrew Chambers, Richard Barry, Ryan Edward Brown, and Stephen Mayo. Learn more on insiders at SRPT. What percentage of Sarepta Therapeutics stock is owned by insiders? 7.70% of Sarepta Therapeutics stock is owned by insiders. Learn more on SRPT's insider holdings. Which Sarepta Therapeutics insiders have been buying company stock? The following insiders have purchased SRPT shares in the last 24 months: Douglas S Ingram ($2,001,856.00), Michael Andrew Chambers ($9,749,217.58), and Richard Barry ($3,940,500.00). How much insider buying is happening at Sarepta Therapeutics? Insiders have purchased a total of 157,109 SRPT shares in the last 24 months for a total of $15,691,573.58 bought. Which Sarepta Therapeutics insiders have been selling company stock? The following insiders have sold SRPT shares in the last 24 months: Bilal Arif ($1,539,325.72), Dallan Murray ($508,900.00), Hans Lennart Rudolf Wigzell ($3,449,550.00), Ian Michael Estepan ($976,059.60), Kathryn Jean Boor ($93,549.73), Ryan Edward Brown ($6,295,840.77), and Stephen Mayo ($385,479.60). How much insider selling is happening at Sarepta Therapeutics? Insiders have sold a total of 93,532 Sarepta Therapeutics shares in the last 24 months for a total of $13,248,705.42 sold. Sarepta Therapeutics Key ExecutivesMr. Douglas S. Ingram Esq. (Age 61)President, CEO & Director Compensation: $1.62MMr. Ian Michael Estepan (Age 48)Executive VP & CFO Compensation: $917.53k1 recent tradesDr. Louise R. Rodino-Klapac Ph.D. (Age 46)Executive VP, Chief Scientific Officer and Head of Research & Development Compensation: $1.04MMr. Ryan E. Brown J.D. (Age 46)Executive VP, General Counsel & Corporate Secretary Compensation: $823.36kMr. Bilal Arif (Age 52)Executive VP & Chief Technical Operations Officer 1 recent tradesMs. Francesca T. NolanExecutive Director of Investor Relations and Corporate CommunicationsMs. Alison NasisiExecutive VP & Chief People OfficerDr. Diane L. Berry Ph.D.Executive VP and Chief of Global Policy & Advocacy OfficerMr. Dallan MurrayExecutive VP & Chief Customer OfficerMr. Will TiltonSenior VP, Head of Strategy & Chief of Staff More Insider Trading Tools from MarketBeat Related Companies Jazz Pharmaceuticals Insider Buying Ionis Pharmaceuticals Insider Buying ACADIA Pharmaceuticals Insider Buying Wave Life Sciences Insider Buying Solid Biosciences Insider Buying BioNTech Insider Buying Teva Pharmaceutical Industries Insider Buying BeiGene Insider Buying Viatris Insider Buying Summit Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:SRPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sarepta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRPT Stock Alerts